Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
NDC Package Code : 59267-9201
Start Marketing Date : 2013-03-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (10mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 59267-9301
Start Marketing Date : 2013-03-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (15mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 59267-9401
Start Marketing Date : 2013-03-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (20mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 59267-5201
Start Marketing Date : 2014-07-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (25mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 59267-5376
Start Marketing Date : 2014-07-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (30mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
NDC Package Code : 59267-5201
Start Marketing Date : 2014-07-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (25mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 59267-9401
Start Marketing Date : 2013-03-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (20mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 59267-5376
Start Marketing Date : 2014-07-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (30mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 59267-9301
Start Marketing Date : 2013-03-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (15mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 59267-9201
Start Marketing Date : 2013-03-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (10mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info :
Registration Country : Australia
Brand Name : Somavert
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Somavert
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Somavert
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : USA
Brand Name : SOMAVERT
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date :
Application Number : 21106
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : SOMAVERT
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date :
Application Number : 21106
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : SOMAVERT
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 30MG/VIAL
Packaging :
Approval Date :
Application Number : 21106
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Somavert
Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
Dosage Strength : 20 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : SOMAVERT
Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
Dosage Strength : 25 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Switzerland
Brand Name : Somavert
Dosage Form : Dry Sub
Dosage Strength : 15mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Canada
Brand Name : SOMAVERT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 10MG/VIAL
Packaging : 8ML
Approval Date :
Application Number : 2272199
Regulatory Info :
Registration Country : Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
FDF DOSSIERS
Reply
19 Feb 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
Comment (4)
